These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1324959)

  • 1. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
    Tsutamoto T; Kanamori T; Wada A; Kinoshita M
    J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure.
    Tsutamoto T; Kanamori T; Morigami N; Sugimoto Y; Yamaoka O; Kinoshita M
    Circulation; 1993 Jan; 87(1):70-5. PubMed ID: 8093432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure.
    Tsutamoto T; Kanamori T; Wada A; Miyauchi N; Murata T; Kinoshita M
    Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
    Arnal JF; Hofmann F; Michel JB
    Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides.
    Tsutamoto T; Sakai H; Yamamoto T; Nakagawa Y
    Int Heart J; 2020 Jan; 61(1):77-82. PubMed ID: 31956150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with heart diseases.
    Nakaoka H; Imataka K; Kitahara Y; Fujii J; Ishibashi M; Yamaji T
    Jpn Circ J; 1988 Jan; 52(1):30-4. PubMed ID: 2834571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.
    Seghaye MC; Duchateau J; Bruniaux J; Demontoux S; Détruit H; Bosson C; Lecronier G; Mokhfi E; Serraf A; Planché C
    Crit Care Med; 1997 Jun; 25(6):1063-70. PubMed ID: 9201062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
    Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
    J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure.
    Abraham WT; Hensen J; Kim JK; Dürr J; Lesnefsky EJ; Groves BM; Schrier RW
    J Am Soc Nephrol; 1992 Jun; 2(12):1697-703. PubMed ID: 1323337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptides in canine hypoxic pulmonary vasoconstriction.
    Vachiery JL; Lejeune P; Hallemans R; Brimioulle S; Debiève MF; Abramow M; Naeije R
    Cardiovasc Res; 1990 May; 24(5):352-7. PubMed ID: 2164881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
    Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
    Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
    Tsutamoto T; Kinoshita M; Ohbayashi Y; Wada A; Maeda Y; Adachi T
    Circulation; 1994 Aug; 90(2):823-9. PubMed ID: 8044954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
    Grantham JA; Borgeson DD; Burnett JC
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with heart disorders during rest and exercise.
    Szekeres T; Artner-Dworzak E; Puschendorf B; Fritzer M; Havel M; Gassner A; Fridrich L
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):69-74. PubMed ID: 8385504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
    Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
    J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
    Berglund H; Nyquist O; Beermann B; Jensen-Urstad M; Theodorsson E
    Br Heart J; 1994 Dec; 72(6):521-7. PubMed ID: 7857733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.